Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
European heart journal · 2022 · 517 citations · Sarju Ganatra
Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF.
Journal of the American College of Cardiology · 2025 · 68 citations · Bruce Hook
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction.
JACC. Heart failure · 2024 · 99 citations · Sourbha Dani, Sarju Ganatra
Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee.
Journal of the American College of Cardiology · 2026 · 18 citations · Sarju Ganatra
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes.
JAMA network open · 2025 · 36 citations · Sourbha Dani, Sarju Ganatra
Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 128 citations · Sarju Ganatra, Sourbha Dani
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors.
JACC. Heart failure · 2024 · 68 citations · Sherif Labib, David Venesy, Sourbha Dani, Sarju Ganatra
Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes.
JACC. Clinical electrophysiology · 2023 · 93 citations · Matthew Reynolds, Sourbha Dani, Sarju Ganatra